Literature DB >> 19234684

[Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders].

J Oldenburg1, S D Fosså.   

Abstract

Due to cisplatin-based chemotherapy, the survival rate of testicular cancer patients approaches 90%. Chemo- or radiotherapy may cause long-term complications, e.g. cardiovascular disease, secondary cancers and reduced fertility. Sperm cryopreservation is recommended depending on the extent of therapy and should be performed before orchiectomy. Furthermore, patients should be informed about long-term complications and their possible reduction by optimizing the risk factor profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234684     DOI: 10.1007/s00120-009-1945-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  30 in total

1.  Long-term renal function after treatment for malignant germ-cell tumours.

Authors:  S D Fosså; N Aass; M Winderen; O P Börmer; D R Olsen
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

2.  Components of the metabolic syndrome in long-term survivors of testicular cancer.

Authors:  H S Haugnes; N Aass; S D Fosså; O Dahl; O Klepp; E A Wist; J Svartberg; T Wilsgaard; R M Bremnes
Journal:  Ann Oncol       Date:  2006-10-23       Impact factor: 32.976

3.  Noncancer causes of death in survivors of testicular cancer.

Authors:  Sophie D Fosså; Ethel Gilbert; Graça M Dores; Jinbo Chen; Katherine A McGlynn; Sara Schonfeld; Hans Storm; Per Hall; Eric Holowaty; Aage Andersen; Heikki Joensuu; Michael Andersson; Magnus Kaijser; Mary Gospodarowicz; Randi Cohen; Eero Pukkala; Lois B Travis
Journal:  J Natl Cancer Inst       Date:  2007-04-04       Impact factor: 13.506

4.  Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.

Authors:  Alexandra W van den Belt-Dusebout; Janine Nuver; Ronald de Wit; Jourik A Gietema; Wim W ten Bokkel Huinink; Patrick T R Rodrigus; Erik C Schimmel; Berthe M P Aleman; Flora E van Leeuwen
Journal:  J Clin Oncol       Date:  2006-01-20       Impact factor: 44.544

5.  Is the sexual function compromised in long-term testicular cancer survivors?

Authors:  Alv A Dahl; Roy Bremnes; Olav Dahl; Olbjørn Klepp; Erik Wist; Sophie D Fosså
Journal:  Eur Urol       Date:  2007-03-01       Impact factor: 20.096

Review 6.  Late relapses of germ cell malignancies: incidence, management, and prognosis.

Authors:  Jan Oldenburg; Jarad M Martin; Sophie D Fosså
Journal:  J Clin Oncol       Date:  2006-12-10       Impact factor: 44.544

7.  Hand-assisted laparoscopic nephrectomy for renal cell cancer with renal vein tumor thrombus.

Authors:  Alastair Henderson; Declan Murphy; Kirubanand Jaganathan; William W Roberts; J Stuart Wolf; Abhay Rané
Journal:  Urology       Date:  2008-05-02       Impact factor: 2.649

Review 8.  European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

Authors:  Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean-Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
Journal:  Eur Urol       Date:  2007-12-26       Impact factor: 20.096

9.  Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).

Authors:  Sophie D Fosså; Ronald de Wit; J Trevor Roberts; Peter M Wilkinson; Pieter H M de Mulder; Graham M Mead; Pat Cook; Linda de Prijck; Sally Stenning; Neil K Aaronson; Andrew Bottomley; Laurence Collette
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

10.  Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.

Authors:  C Bokemeyer; C C Berger; J T Hartmann; C Kollmannsberger; H J Schmoll; M A Kuczyk; L Kanz
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.